Quantib Brain 1

Quantib Brain 1 is a medical imaging software designed to provide automated volumetric quantification of brain structures from MR images, including grey matter, white matter, CSF, and white matter hyperintensities, to support clinical assessment. The system utilizes an atlas-based segmentation methodology, integrating histogram analysis and trained classifiers for enhanced white matter hyperintensity detection, and functions as a post-processing plugin for GE Advantage Workstation platforms.

Quantib Brain 1 is a post-processing medical imaging software designed for GE Advantage (AW 4.7) and AW Server (AWS 3.2) platforms. Its primary purpose is to automate the labeling, visualization, and volumetric quantification of identifiable brain structures from Magnetic Resonance (MR) images, specifically utilizing 3D T1-weighted MR scans, with an additional T2-weighted FLAIR MR image for white matter hyperintensities (WMH) segmentation. The software's methodology aims to provide clinicians with both absolute and relative volume measurements of these structures, aiding in the evaluation, assessment, and quantitative reporting of MR brain images; a key aspect of its workflow includes mandatory user review and potential editing of automatically detected WMH candidates prior to their validation and subsequent volumetric analysis. The core science of Quantib Brain 1 is founded on an atlas-based segmentation system, which employs a library of atlases, each comprising a 3D T1-weighted MR image and a corresponding label map for dividing the image into different tissue segments; this is further refined for WMH segmentation through the integration of histogram analysis and trained classifiers to improve accuracy. Performance data, derived from comparisons with manual segmentations, showed that for brain tissue volumetry (Grey Matter, White Matter, CSF, Intracranial Volume) on 33 T1w MR images, Dice similarity coefficients ranged from 0.78 for CSF to 0.97 for ICV, with absolute differences in relative volumes between 1.6 and 2.8 percentage points. For the WMH protocol tested on 30 image sets, the software achieved an average Dice overlap of 0.61 ± 0.13 and an absolute difference in relative WMH volumes of 0.6 ± 0.7 percentage points when compared to manual segmentations.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the performance of Quantib Brain's atlas-based segmentation for WMH (Dice 0.61 ± 0.13) compare to state-of-the-art deep learning models in terms of both accuracy and computational efficiency on typical clinical MR scans?; What is the typical time required for user review and editing of WMH candidates, and how does this impact overall workflow efficiency in a busy clinical radiology setting?; How does the variability in MR acquisition parameters (e.g., scanner vendor, field strength, sequence parameters beyond the specified 3D T1w or T2w FLAIR) affect the robustness and accuracy of Quantib Brain's segmentation results?; Are there specific patient populations or types of brain pathology (beyond WMH) where Quantib Brain's current atlas-based approach might be less accurate, and what are the plans to address such limitations?; Given the quantitative outputs (e.g., absolute/relative volumes), what is the evidence or plan for validating their clinical utility in diagnosing specific neurological conditions or monitoring disease progression beyond general 'assessment'?